The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma.

The therapeutic value of LND in RCC is still unclear, and although prospective data are needed, its declining rates and emerging new therapies make this unlikely. A better understanding of renal lymphatics and improved detection of nodal disease may help determine the role of LND in nonmetastatic localized RCC.